Literature DB >> 21075821

Mortality rate comparison after switching from continuous to prolonged intermittent renal replacement for acute kidney injury in three intensive care units from different countries.

Mark R Marshall1, Julie M Creamer, Michelle Foster, Tian M Ma, Susan L Mann, Enrico Fiaccadori, Umberto Maggiore, Brent Richards, Vanessa L Wilson, Anthony B Williams, Alan P N Rankin.   

Abstract

BACKGROUND: Prolonged intermittent renal replacement therapy (PIRRT) is a dialysis modality for critically ill patients that in theory combines the superior detoxification and haemodynamic stability of the continuous renal replacement therapy (CRRT) with the operational convenience, reduced haemorrhagic risk and low cost of conventional intermittent haemodialysis. However, the extent to which PIRRT should replace these other modalities is uncertain because comparative studies of mortality are lacking. We retrospectively examined the mortality data from three general intensive care units (ICUs) in different countries that have switched their predominant therapeutic approach from CRRT to PIRRT. We assessed whether this practice change was associated with a change in mortality rate.
METHODS: Data were analysed from ICUs in New Zealand, Australia and Italy. The study population comprised all patients requiring renal replacement therapy from 1 January 1995 to 31 December 2005 (n = 1347), the period of time spanning the change from CRRT to PIRRT in each unit. Poisson regression models were used to estimate the incident rate ratio (IRR) for death, comparing the periods before and after change to PIRRT in each unit. Estimates were adjusted for patient illness severity (APACHE II score) and for the underlying time trend in mortality rate over time.
RESULTS: The change from CRRT to PIRRT was not associated with any increase in mortality rate, with an adjusted IRR of 1.02 (0.61-1.71). The IRR was virtually identical in the three ICUs (P-value = 0.63 for the difference in the IRR between ICUs).
CONCLUSIONS: Switching from CRRT to PIRRT was not associated with a change in mortality rate. Pending the results of a randomized trial, our study provides evidence that PIRRT might be equivalent to CRRT in the general ICU patient.

Entities:  

Mesh:

Year:  2010        PMID: 21075821     DOI: 10.1093/ndt/gfq694

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  14 in total

1.  Efficacy and safety of a citrate-based protocol for sustained low-efficiency dialysis in AKI using standard dialysis equipment.

Authors:  Enrico Fiaccadori; Giuseppe Regolisti; Carola Cademartiri; Aderville Cabassi; Edoardo Picetti; Maria Barbagallo; Tiziano Gherli; Giuseppe Castellano; Santo Morabito; Umberto Maggiore
Journal:  Clin J Am Soc Nephrol       Date:  2013-08-29       Impact factor: 8.237

Review 2.  Choice of renal replacement therapy modality and dialysis dependence after acute kidney injury: a systematic review and meta-analysis.

Authors:  Antoine G Schneider; Rinaldo Bellomo; Sean M Bagshaw; Neil J Glassford; Serigne Lo; Min Jun; Alan Cass; Martin Gallagher
Journal:  Intensive Care Med       Date:  2013-02-27       Impact factor: 17.440

Review 3.  Regional citrate anticoagulation for renal replacement therapies in patients with acute kidney injury: a position statement of the Work Group "Renal Replacement Therapies in Critically Ill Patients" of the Italian Society of Nephrology.

Authors:  Enrico Fiaccadori; Valentina Pistolesi; Filippo Mariano; Elena Mancini; Giorgio Canepari; Paola Inguaggiato; Marco Pozzato; Santo Morabito
Journal:  J Nephrol       Date:  2015-01-14       Impact factor: 3.902

Review 4.  Current and Potential Therapeutic Strategies for Hemodynamic Cardiorenal Syndrome.

Authors:  Yoshitsugu Obi; Taehee Kim; Csaba P Kovesdy; Alpesh N Amin; Kamyar Kalantar-Zadeh
Journal:  Cardiorenal Med       Date:  2015-11-06       Impact factor: 2.041

5.  Modality of RRT and Recovery of Kidney Function after AKI in Patients Surviving to Hospital Discharge.

Authors:  Kelly V Liang; Florentina E Sileanu; Gilles Clermont; Raghavan Murugan; Francis Pike; Paul M Palevsky; John A Kellum
Journal:  Clin J Am Soc Nephrol       Date:  2015-12-17       Impact factor: 8.237

6.  Strategies for Continuous Renal Replacement Therapy De-escalation.

Authors:  Samir C Gautam; Nityasree Srialluri; Bernard G Jaar
Journal:  Kidney360       Date:  2021-04-15

Review 7.  Fluid management for the prevention and attenuation of acute kidney injury.

Authors:  John R Prowle; Christopher J Kirwan; Rinaldo Bellomo
Journal:  Nat Rev Nephrol       Date:  2013-11-12       Impact factor: 28.314

Review 8.  Regional citrate anticoagulation for RRTs in critically ill patients with AKI.

Authors:  Santo Morabito; Valentina Pistolesi; Luigi Tritapepe; Enrico Fiaccadori
Journal:  Clin J Am Soc Nephrol       Date:  2014-07-03       Impact factor: 8.237

9.  Walkaway PIRRT (as SLED) for Acute Kidney Injury.

Authors:  Anna Burgner; Thomas Golper
Journal:  Clin J Am Soc Nephrol       Date:  2020-09-11       Impact factor: 8.237

10.  Outcomes of sustained low efficiency dialysis versus continuous renal replacement therapy in critically ill adults with acute kidney injury: a cohort study.

Authors:  Abhijat Kitchlu; Neill Adhikari; Karen E A Burns; Jan O Friedrich; Amit X Garg; David Klein; Robert M Richardson; Ron Wald
Journal:  BMC Nephrol       Date:  2015-08-04       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.